Psychopharmacological effects of tianeptine analogous hetero[2,1] benzothiazepine derivatives

Arzneimittel-Forschung/Drug Research

Volumn 53, Issue 1, 2003, Pages 12-20

  Sánchez Mateo, Candelaria C ^a   Darias, Victoriano ^a   Albertos, Luz M ^a   Expósito Orta, María A ^a  

^a UNIVERSIDAD DE LA LAGUNA   (Spain)

Author keywords

Antidepressants; Antipsychotics; Anxiolytics; CAS 66981 73 5; Heterobenzothiazepine derivatives, mice, psychopharmacology; Tianeptine analogues

Indexed keywords

5 HYDROXYTRYPTOPHAN; AMITRIPTYLINE; AMPHETAMINE; APOMORPHINE; BENZODIAZEPINE DERIVATIVE; CHLORPROMAZINE; DEXAMPHETAMINE; DIAZEPAM; DOPAMINE UPTAKE INHIBITOR; FLUOXETINE; HALOPERIDOL; IMIPRAMINE; MONOAMINE OXIDASE INHIBITOR; PENTETRAZOLE; STRYCHNINE; TIANEPTINE; TRANYLCYPROMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; EXPLORATORY BEHAVIOR; FEMALE; HYPOTHERMIA; MALE; MAZE TEST; MOUSE; MUSCLE RELAXATION; NONHUMAN; PSYCHOPHARMACOLOGY; TRANQUILIZING ACTIVITY;

EID: 0037241377     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1297064     Document Type: Article

References (25)

1. Vega, S., Díaz, J. A., Synthesis of thieno[3,4-c] and thieno[3,2-c][2,1] benzothiazepines. J. Heterocyclic Chem. 30, 1509 (1993)
2. Vega, S., Díaz, J. A., Synthesis of 1H- and 2H-pyrazolo[3,4-c][2,1] benzothiazepines. J. Heterocyclic Chem. 31, 93 (1994)
3. Vega, S., Díaz, J. A., Spanish Patent 2021548. 1991; C. A. 116, P214543s (1992)
4. Mocaër, E., Rettori, M. C., Kamoun, A., Pharmacological antidepressive effects and tianeptine-induced 5-HT uptake increase. Clin. Neuropharmacol. 11 (Suppl. 2), S32 (1988)
5. Wilde, M. I., Benfield, P., Tianeptine: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depression and coexisting anxiety and depression. Drugs 49, 411 (1995)
6. Vega, S., Díaz, J. A., Darias, V. et al., Antidepressant activity of new hetero [2,1]benzothiazepine derivatives. Pharmazie 53, 130 (1998)
7. Pellow, S., File, S. E., Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat. Pharmacol. Biochem. Behav. 24, 525 (1986)
8. Lister, R. G., The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology 92, 180 (1987)
9. Boissier, J. R., Simon, P., La réaction d'exploration chez la souris. Thérapie 17, 1225 (1962)
10. Tallarida, R. J., Murray, R. B., in: Manual of Pharmacologic Calculations with Computer Programs, 2nd ed. Springer Verlag, New York (1986)
11. Bourin, M., in: Les Antidepresseurs, pp. 35-51. Ellipses, Paris (1983)
12. Bourin, M., Is it possible to predict the activity of a new antidepressant in animals with simple psychopharmacological tests? Fundam. Clin. Pharmacol. 4, 49 (1990)
13. Puech, A. J., Chermat, R., Poncelet, M. et al., Antagonism of hypothermia and behavioural response to apomorphine: a simple rapid and discriminating test for screening antidepressants and neuroleptics. Psychopharmacology 75, 84 (1981)
14. Pawlowski, L., Mazela, H., Effects of antidepressant drugs, selective noradrenaline- or 5-hydroxytryptamine uptake inhibitors, on apomorphine-induced hypothermia in mice. Psychopharmacology 88, 240 (1986)
15. Ortmann, R., Waldmeir, P. C., Radeke, E. et al., The effects of 5-HT uptake- and MAO inhibitors on L-5-HTP- induced excitation in rats. Naunyn Schmiedebergs Arch. Pharmacol. 311, 185 (1980)
16. Puech, A. J., Simon, P., Boissier, J., Benzamides and classical neuroleptics: Comparison of their actions using 6 apomorphine-induced effects. Eur. J. Pharmacol. 50, 291 (1978)
17. Costentin, J., Petit, M., Dollfus, S., in: Les neuroleptiques: De la neurobiologie des transmissions dopaminergiques a la thérapeutique, pp. 101-143. Ellipses, Paris (1987)
18. Worms, P., in: The benzamides: Pharmacology, neurobiology and clinical aspects, J. Rotrosen, M. Stanley (eds.), pp. 7-16. Raven Press, New York (1982)
19. Heffner, T. G., Downs, D. A., Meltzer, L. T. et al., CI-943, a potential antipsychotic agent. I. Preclinical behavioural effects, J. Pharmacol. Exp. Ther. 251, 105 (1989)
20. Moore, N. A., Tye, N. C., Axton, M. S. et al., The behavioural pharmacology of olanzapine, a novel "atypical antipsychotic agent. J. Pharmacol. Exp. Ther. 262, 545 (1992)
21. Sank, R. P., Gardocki, J. F., Schneider, C. R. et al., Preclinical evaluation of McN-5707 as a potential antidepressant. J. Pharmacol. Exp. Ther. 242, 74 (1987)
22. 1C receptors. Neurosci. Biobehav. Rev. 18, 95 (1992)
23. Eison, A. S., Eison, M. S., Serotonergic mechanisms in anxiety. Prog. Neuro-Psychopharmacol. Biol. Psychiat. 18, 47 (1994)
24. Berendsen, H. H. G., Interactions between 5-hydroxytryptamine receptor subtypes: Is a disturbed receptor balance contributing to the symptomatology of depression in humans? Pharmacol. Ther. 66, 17 (1995)
25. Luki, I., The spectrum of behaviours influenced by serotonin. Biol. Psychiat. 44, 151 (1998)